Notice of Change to RFA-MH-18-706, Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)

Notice Number: NOT-MH-18-030

Key Dates
Release Date: March 23, 2018

Related Announcements
RFA-MH-18-706

Issued by
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to notify potential applicants of the revision in, "RFA-MH-18-706, Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)" of the foreign component eligibility requirements. The following section of the FOA is revised accordingly:

Part 2. Section III. Eligibility Information
1. Eligible Applicants

Current Language
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Revised Language
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.


All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Joel Sherrill, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-2477
Email: jsherril@mail.nih.gov